Few Pharmas Expect to Meet EVMPD Deadline
Technology company's survey reveals only 15% of big pharma, 35% mid-size pharma are optimistic about submitting all required data in time
Polling conducted by the US based technology company revealed that most pharmaceutical companies are concerned about their ability to comply with the requirement to submit additional pharmacovigilance data to the EMA EudraVigilance Medicinal Product Dictionary (EVMPD) in advance of the July 2, 2012 deadline.
To find more information please use the below mentioend weblink
http://www.linkedin.com/groups/Few-Pharmas-Expect-Meet-EVMPD-4334168.S.99276687?view=&gid=4334168&type=member&item=99276687
No comments:
Post a Comment